GLP1 hormone is naturally produced in the body while GLP-1 supplements are synthetic molecules that are not produced by the body. Incretin hormones are special chemicals in the stomach (gastrointestinal peptides) that help the body make more insulin when needed.
The two main ones are called GLP-1 and GIP. GLP-1 and GIP do a lot of good things for people with diabetes. They help make more insulin when our blood sugar is high, and they don’t do anything when it’s not. [1]
There are also special medicines that act like these hormones to help people with diabetes even more. These medicines work by activating the same receptors as GLP-1 and GIP, but they last longer in our bodies. They are some of the newest kinds of diabetes medications.
GLP-1 mimetics and analogs have revolutionized the treatment of type 2 diabetes by harnessing the potential of this natural hormone. Exploring how GLP-1 works and its therapeutic applications opens up new possibilities for patients striving to achieve better metabolic health.
Why It’s Important to Know Their Significant Difference
GLP-1 plays a crucial role in controlling glucose levels, promoting insulin production, and curbing appetite. Understanding the impact of GLP1 hormone on the body can provide valuable insights into managing diabetes mellitus and obesity.
As patients need to be aware that while natural GLP-1 helps regulate blood sugar levels after meals, synthetic versions can provide more sustained effects throughout the day. This could impact their treatment choices and management of diabetes.
Better Understanding
Knowing the distinction between natural and synthetic GLP-1 hormones allows patients to have meaningful discussions with healthcare providers about treatment options. It also enables them to understand how these medications work in their bodies and what potential side effects they may experience.
Effective Decision Making
By being well-informed about these differences, patients can actively participate in shared decision-making with healthcare professionals regarding their diabetes management plan. They can weigh factors such as administration method (injection or oral agents), frequency of dosing, potential risks, benefits, and expected outcomes when choosing between natural or synthetic GLP-1 treatments.
Increased Knowledge
Moreover, understanding this difference can help patients recognize any adverse reactions related to their medication use. For instance, if a patient experiences symptoms that align more closely with those associated with synthetic rather than natural GLP-1 hormones (such as injection site reactions), they can promptly communicate this information to their healthcare provider for proper evaluation and adjustment of treatment if necessary.
What is GLP-1
Glucagon-like peptide 1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone that plays a crucial role in the regulation of blood sugar levels. It is produced and secreted by intestinal enteroendocrine L-cells and certain neurons within the nervous system. [2]
GLP-1 has several physiological functions, including:
- Stimulation of insulin secretion from pancreatic beta-cells
- Inhibition of glucagonemia
- Decrease of gastric emptying
- Inhibition of food intake
- Increase of natriuresis and diuresis
- Modulation of rodent β-cell proliferation
GLP-1 exists in natural and synthetic forms. The natural form is produced by the body’s intestinal cells in response to food intake. On the other hand, synthetic forms are artificially created to mimic the functions of naturally occurring GLP-1.
The natural form of GLP1 hormone plays a crucial role in regulating insulin and glucagon secretion in response to meals. However, it has a short half-life due to rapid degradation by an enzyme called dipeptidyl peptidase-4 (DPP-4).
In contrast, synthetic versions have been developed with enhanced stability against DPP-4 degradation.
Understanding GLP1 Hormone
The GLP1 hormone does more than just control blood sugar. It also helps protect the heart and brain, reduces inflammation, and controls appetite. Scientists have used this hormone to make medicines for type 2 diabetes and other similar problems.
Organs Responsible for Endogenous GLP-1 Production
The endogenous GLP-1 is primarily produced and released by the intestinal L-cells, which are located in the lower gastrointestinal tract. These specialized cells secrete GLP-1 in response to the ingestion of nutrients, especially carbohydrates and fats.
The organs responsible for endogenous GLP-1 production are:
- Pancreatic α-cells: GLP-1 is derived from the precursor hormone glucagon, which is expressed in pancreatic α-cells. [4]
- Enteroendocrine L-cells: GLP-1 is primarily produced by enteroendocrine L-cells throughout the gastrointestinal tract, predominantly in the distal ileum and colon. [3]
- Neurons of the nucleus tractus solitarius (NTS): GLP-1 is also synthesized to a lesser extent by neurons of the NTS in the brain. [5]
These cells and tissues work together to regulate blood sugar levels, appetite, and food intake. The understanding of GLP-1 and its actions has led to the development of medications to treat type 2 diabetes mellitus and other related conditions.
Factors Influencing the Release of Endogenous GLP-1
Several factors influence the release of endogenous GLP-1, including food intake, gut hormones, neural signals, and metabolic cues. When an individual consumes a meal rich in nutrients, particularly glucose and fatty acids, it triggers the secretion of GLP-1 from the L-cells into the bloodstream.
Nutrients such as glucose and fatty acid stimulate endogenous GLP-1 secretion. For instance, when carbohydrates enter the digestive system during a meal, they prompt an increase in blood sugar levels. This rise in blood glucose levels stimulates L-cells to release GLP-1, which then acts on various organs to regulate insulin production and control blood sugar levels.
Overview of GLP-1 Agonists and Their Function
GLP-1 receptor agonists, also known as GLP-1 mimetics or analogs, are a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity.
These medications that mimic natural incretin hormones help manage blood sugar levels by triggering the pancreas to release more insulin, slowing digestion to decrease blood sugar spikes, and reducing food intake, appetite, and hunger, which often result in significant weight loss 2.
Understanding GLP-1 Agonists for Type 2 Diabetes
GLP-1 agonists are superior to other antihyperglycemic drugs in improving and reducing weight and blood pressure, and having a cardioprotective effect, all without the risk of hypoglycemia.
These drugs cannot treat type 2 diabetes or obesity on their own and require other treatment strategies, such as lifestyle and dietary changes.
List of GLP-1 Agonists for Diabetes Management
GLP-1 agonists are most often injectable medications, and there are currently seven GLP-1 receptor agonists:
- Exenatide (Byetta, Bydureon) – subcutaneously twice daily.
- Exenatide extended-release (Bydureon) – subcutaneously once weekly.
- Liraglutide (Victoza, Saxenda) – subcutaneously once daily.
- Dulaglutide (Trulicity) – subcutaneously once weekly.
- Lixisenatide (Wegovy) – orally once daily.
- Semaglutide (Ozempic, Wegovy, Rybelsus) – subcutaneously once weekly.
- Tirzepatide (Mounjaro) – a dual GLP-1/GIP receptor agonist administered subcutaneously once weekly.
Comparing different brands of GLP-1 drugs can help patients understand their options. For instance, some may prefer a once-weekly injection over daily injections for convenience. The cost and insurance coverage may also vary between different brands.
The Difference of GLP-1 Hormones vs GLP-1 Supplements
Natural and Synthetic Function
GLP1 hormone occurs naturally in the body, produced by the intestines, while GLP-1 supplements are artificially created versions of this hormone. The natural form is secreted in response to food intake and regulates insulin release, slowing down digestion, and reducing appetite.
Therapeutic Use vs. Dietary Supplementation
For therapeutic use, doctors prescribe GLP-1 agonists (hormones) to patients with type 2 diabetes as they mimic the action of the natural hormone. On the other hand, dietary supplementation involves consuming synthetic forms found in nutritional products for potential weight management benefits.
Patients prescribed with GLP1 hormone receive them through injections or oral medications under medical supervision to manage blood sugar levels effectively.
Mechanism of Action
When comparing their mechanisms of action, it’s important to note that GLP-1 hormones directly affect pancreatic function by increasing insulin secretion and decreasing glucagon production from the pancreas.
In contrast, GLP-1 supplements primarily focus on influencing satiety signals within the brain and gastrointestinal tract without directly impacting insulin or glucagon levels.
Variances between Hormones and Supplements
While both can lead to improved glycemic control, there are differences in how they achieve this effect. For instance, GLP-1 hormones not only lower blood sugar but also aid weight loss due to their effects on appetite suppression and delayed gastric emptying.
Conversely, supplements may help reduce food intake but do not have a significant impact on body weight compared to hormonal treatments used therapeutically for managing diabetes or obesity-related conditions.
GLP1 Hormone Impact on Blood Sugar Control
Role of Endogenous GLP-1 in Glucose Regulation
When patients consume food, the gut releases GLP1 hormone, which then stimulates insulin secretion and inhibits glucagon release from the pancreas. This process helps to lower postprandial glucose levels and maintain overall glycemic control.
GLP 1 hormone function slows down gastric emptying, reducing the rate at which glucose enters the bloodstream after meals. Natural GLP hormone also enhances insulin sensitivity in tissues such as muscle and liver.
By improving insulin sensitivity, it allows cells to better utilize glucose for energy production or storage instead of letting it accumulate in the blood. This mechanism is vital for maintaining healthy blood glucose levels and preventing hyperglycemia.
Influence on Insulin Sensitivity
Patients with type 2 diabetes often experience reduced insulin sensitivity, leading to elevated blood sugar levels due to poor utilization of available insulin. The natural action of GLP-1 hormones can counteract this issue by increasing cellular responsiveness to insulin.
For instance, when individuals exercise or lose weight through lifestyle modifications like getting into best diet changes or physical activity, their bodies produce more endogenous GLP-1 hormones naturally.
In cases where these natural mechanisms are insufficient for achieving optimal glycemic efficacy and addressing persistent high blood sugar levels or worsening insulin resistance over time, healthcare providers might prescribe injectable or oral medication that mimics the effects of endogenous GLP1 hormone.
GLP-1 and Appetite Regulation
Satiety Signals
The GLP1 hormone plays a crucial role in regulating appetite by influencing satiety signals. When released, it communicates with the brain to signal fullness, reducing the urge to eat. This natural process helps individuals manage their food intake and maintain a healthy body weight. [6]
GLP-1 is responsible for modulating hunger and food intake. As it interacts with the brain, it sends signals that help control cravings and prevent overeating. Essentially, this hormone acts as a built-in mechanism for managing appetite.
Mimicking Impact
Mimicking the impact of natural GLP-1 on satiety has shown potential for aiding in weight management efforts. By understanding how GLP1 hormone influences feelings of fullness, researchers have developed medications such as injectable semaglutide to replicate these effects artificially.
Injectable semaglutide belongs to the semaglutide group, which has demonstrated promise in promoting weight reduction among individuals struggling with chronic weight management issues. The medication works by mimicking the actions of natural GLP-1, helping patients feel fuller for longer periods while consuming fewer calories.
Weight Loss Potential
By leveraging the knowledge about natural GLP-1’s impact on satiety signals, pharmaceutical advancements have led to innovations like an oral semaglutide tablet designed specifically for addressing weight management concerns.
Clinical trials involving oral semaglutide have also indicated its potential to support significant reductions in body weight when used as part of a comprehensive treatment plan.
Individuals seeking effective solutions for combating weight gain may benefit from exploring options. Medications derived from research into natural GLP-1’s influence on appetite regulation offer hope for those striving to achieve sustainable weight loss outcomes.
Conclusion
The GLP1 hormone plays a crucial role in regulating blood sugar levels. It stimulates insulin production, which helps to lower blood glucose after meals. It reduces the secretion of glucagon, a hormone that increases blood sugar levels.
GLP-1 medications have been shown to have significant benefits for individuals with type 2 diabetes. They can help improve glycemic control by having Hba1c reduction in levels and promoting weight loss.
Using GLP-1 medications can lead to improved overall health outcomes for individuals struggling with type 2 diabetes.
It is important for individuals considering the use of GLP-1 supplements to consult healthcare professionals before starting any new medication regimen. Healthcare professionals can provide tailored advice based on each patient’s unique medical history and needs.
GLP-1 Shots Companion: Korbiotic
Supporting Synthetic GLP-1 Shots
Synthetic GLP-1 analogs like WeGovy, Saxenda, and Zepbound are engineered to resist and act like the natural GLP-1 hormone.
However, it may lack holistic support provided by natural sources. Our advanced probiotic supplement not only supports the effectiveness of synthetic GLP-1 shots.
Korbiotic also nurtures a healthy gut environment, mimicking the benefits of natural GLP-1 production.
Key Takeaways
- Understanding the difference between natural GLP-1 and GLP-1 supplements is crucial for individuals seeking effective blood sugar control and appetite regulation.
- GLP1 hormone plays a vital role in regulating blood sugar levels and controlling appetite, making it essential for individuals with diabetes or weight management concerns.
- Consider exploring GLP-1 agonists as a potential treatment option, as they can mimic the effects of natural GLP-1 to help manage blood sugar and reduce appetite.
- When evaluating the impact of natural GLP-1 on blood sugar control, consider incorporating lifestyle changes such as diet and exercise to support its function.
- Recognizing the significance of natural GLP-1 in appetite regulation and blood sugar control can empower individuals to make informed decisions about their health and treatment options.
GLP-1 FAQs
Can the body become resistant to endogenous GLP-1?
Yes, the body can develop resistance to its own GLP1 hormone over time, leading to reduced effectiveness in blood sugar control and appetite regulation.
Are there side effects in GLP-1 medication?
The side effects of synthetic GLP-1 supplements, or GLP-1 receptor agonists (GLP-1RAs), primarily include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. Other common adverse effects may include headache, loss of appetite, abdominal pain, and injection site reactions. These effects are generally mild to moderate and often decrease over time as the body adjusts to the medication. Severe but rare side effects can include allergic reactions at the injection site and potentially anaphylaxis, a severe allergic reaction. There is also a low risk of mild low blood sugar (hypoglycemia) episodes, which can become a serious risk if GLP-1RAs are taken with other medications that lower blood sugar, such as sulfonylureas or insulin.
Are there dietary restrictions when using GLP-1 medications?
While no specific diet is mandated, it’s advisable to maintain a healthy eating pattern consistent with diabetes management. Avoiding high-fat meals can help prevent gastrointestinal side effects associated with these medications.
Can GLP-1 medications be used in combination with other diabetes treatments?
Yes, they are often prescribed alongside other diabetes drugs like metformin or sulfonylureas for improved glycemic control. However, always consult your healthcare provider for personalized treatment recommendations.
Can individuals without diabetes use GLP-1 medications for appetite control?
Some GLP-1 agonists, such as semaglutide, have been specifically made and approved as weight loss drugs. These medications are consistently more effective in patients without diabetes than in those with diabetes. Therefore, they can be used as an effective weight loss strategy in individuals without diabetes.
References:
[1] M. A. Nauck, “Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective,” Acta Diabetologica, vol. 35, no. 3, pp. 117–129, Oct. 1998, doi: https://doi.org/10.1007/s005920050116.
[2] X. Zhao et al., “GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects,” Frontiers in Endocrinology, vol. 12, Aug. 2021, doi: https://doi.org/10.3389/fendo.2021.721135.
[3] R. Abu-Hamdah, A. Rabiee, G. S. Meneilly, R. P. Shannon, D. K. Andersen, and D. Elahi, “The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 6, pp. 1843–1852, Jun. 2009, doi: https://doi.org/10.1210/jc.2008-1296.
[4] T. D. Müller et al., “Glucagon-like peptide 1 (GLP-1),” Molecular Metabolism, vol. 30, pp. 72–130, Dec. 2019, doi: https://doi.org/10.1016/j.molmet.2019.09.010.
[5] A. M. Bodnaruc, D. Prud’homme, R. Blanchet, and I. Giroux, “Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review,” Nutrition & Metabolism, vol. 13, no. 1, Dec. 2016, doi: https://doi.org/10.1186/s12986-016-0153-3.
[6] O. B. Chaudhri, V. Salem, K. G. Murphy, and S. R. Bloom, “Gastrointestinal Satiety Signals,” Annual Review of Physiology, vol. 70, no. 1, pp. 239–255, Mar. 2008, doi: https://doi.org/10.1146/annurev.physiol.70.113006.100506.